101 related articles for article (PubMed ID: 7384639)
1. Competitive fluorescence polarization study of the binding of 1,4-dihydroxy-5,8-bis[(2-[(2-hydroxyethyl) amino] ethyl]amino] 9-10-anthracenedione to DNA.
Richardson CL; Roboz J; Holland JF
Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):497-506. PubMed ID: 7384639
[TBL] [Abstract][Full Text] [Related]
2. Competitive binding studies of compounds that interact with DNA utilizing fluorescence polarization.
Richardson CL; Schulman GE
Biochim Biophys Acta; 1981 Jan; 652(1):55-63. PubMed ID: 7213736
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the interaction of antineoplastic aminoanthraquinone analogs with DNA using competitive fluorescence polarization.
Roboz J; Richardson CL; Holland JF
Life Sci; 1982 Jul; 31(1):25-30. PubMed ID: 7109851
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence polarization studies of the binding of BMS 181176 to DNA.
Krishnan BS; Moore ME; Lavoie CP; Long BH; Dalterio RA; Wong HS; Rosenberg IE
J Biomol Struct Dyn; 1994 Dec; 12(3):625-36. PubMed ID: 7727062
[TBL] [Abstract][Full Text] [Related]
5. Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization.
Richardson CL; Grant AD; Schpok SL; Krueger WC; Li LH
Cancer Res; 1981 Jun; 41(6):2235-40. PubMed ID: 7237423
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
Lown JW; Hanstock CC; Bradley RD; Scraba DG
Mol Pharmacol; 1984 Jan; 25(1):178-84. PubMed ID: 6708933
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.
Von Hoff DD; Pollard E; Kuhn J; Murray E; Coltman CA
Cancer Res; 1980 May; 40(5):1516-8. PubMed ID: 7370989
[TBL] [Abstract][Full Text] [Related]
8. Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids.
Kapuscinski J; Darzynkiewicz Z; Traganos F; Melamed MR
Biochem Pharmacol; 1981 Feb; 30(3):231-40. PubMed ID: 7225141
[No Abstract] [Full Text] [Related]
9. [Competitive interaction of serotonin and the dye acridine orange with DNA].
Strakhovskaia MG; Kirpichnikova NA; Fraĭkin GIa
Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (11):33-6. PubMed ID: 3545304
[TBL] [Abstract][Full Text] [Related]
10. Metal mutagens and carcinogens effectively displace acridine orange from DNA as measured by fluorescence polarization.
Richardson CL; Verna J; Schulman GE; Shipp K; Grant AD
Environ Mutagen; 1981; 3(5):545-53. PubMed ID: 6793355
[TBL] [Abstract][Full Text] [Related]
11. Interaction of antitumour agent mitoxantrone with poly[d(G-C)]--a circular dichroic study.
Rao MV; Atreyi M; Kumar A
Indian J Biochem Biophys; 1989 Feb; 26(1):5-8. PubMed ID: 2777312
[TBL] [Abstract][Full Text] [Related]
12. Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acids.
Sinha BK
Chem Biol Interact; 1980 Apr; 30(1):67-77. PubMed ID: 7379206
[TBL] [Abstract][Full Text] [Related]
13. [The study of the interaction of antineoplastic drugs mitoxantrone and ametantrone with DNA using the analysis of changes in circular dichroism spectra].
Babaian IuS; Sngrian AE; Kazarian RS; Avetisian MG; Sogomonian LR; Garibian DV
Biofizika; 1998; 43(3):422-6. PubMed ID: 9702332
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.
Agarwal S; Jangir DK; Mehrotra R
J Photochem Photobiol B; 2013 Mar; 120():177-82. PubMed ID: 23266050
[TBL] [Abstract][Full Text] [Related]
15. Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione.
Savaraj N; Lu K; Valdivieso M; Burgess M; Umsawasdi T; Benjamin RS; Loo TL
Clin Pharmacol Ther; 1982 Mar; 31(3):312-6. PubMed ID: 7060314
[TBL] [Abstract][Full Text] [Related]
16. The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation.
Rosenberg LS; Carvlin MJ; Krugh TR
Biochemistry; 1986 Mar; 25(5):1002-8. PubMed ID: 2870736
[TBL] [Abstract][Full Text] [Related]
17. Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
Kharasch ED; Novak RF
Biochem Pharmacol; 1981 Oct; 30(20):2881-4. PubMed ID: 6274352
[No Abstract] [Full Text] [Related]
18. Sequence specificity in DNA for the interaction with adriamycin or daunomycin.
Vedaldi D; Dall'Acqua F; Caffieri S; Rodighiero G
Farmaco Sci; 1982 Sep; 37(9):571-81. PubMed ID: 7128814
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence enhancement of bis-acridine orange peptide, BAO, upon binding to double stranded DNA.
Mizuki K; Sakakibara Y; Ueyama H; Nojima T; Waki M; Takenaka S
Org Biomol Chem; 2005 Feb; 3(4):578-80. PubMed ID: 15703790
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding abilities of bisguanylhydrazones of anthracene-9,10-dicarboxaldehyde.
Foye WO; Karnik PS; Sengupta SK
Anticancer Drug Des; 1986 Apr; 1(2):65-71. PubMed ID: 2453195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
